Advertisement

The Latest

The FDA has approved Scholar Rock’s ISEMBYLD for spinal muscular atrophy in adults and children ages 2 and older who are currently receiving a survival motor neuron 2-targeted treatment. ISEMBYLD is the first muscle-targeted treatment approved for children and adults…

Three group purchasing organizations served as the primary GPOs for more than 80% of U.S. hospitals in 2024, according to a study published Sept. 11 in JAMA Health Forum. Here are five things to know:

New clinical findings, legal settlements and expanding use cases are shaping the GLP-1 landscape across oncology, pediatrics and addiction care. Here are nine GLP-1 updates to know.

Ten hospitals and health systems recently posted job listings seeking revenue cycle management expertise. Note: This is not an exhaustive list. Listings were compiled from job-seeker sites. 1. Advent Health, based in Altamonte Springs, Fla., seeks a vice president and…

In this episode, Kevin McGeachy, FACHE, President of Mather Hospital, joins the podcast to discuss the importance of prioritizing the patient experience and reducing readmissions. He also shares insights on the critical role of employee engagement in creating a strong…

In this episode, Mike Sanky, Vice President of Healthcare & Life Sciences GTM, Databricks, discusses how health plans can modernize data and AI capabilities to manage rising costs, improve utilization insights and strengthen governance for scalable AI adoption. This episode…

In this episode, Patrick Seiler, CFO, Advanced Reconstructive Surgery Alliance, and Seth Pfaltzgraff, Healthcare Client Director, Macedon Technologies, discuss using data, automation and AI to improve physician practice operations, revenue cycle performance and financial outcomes.  This episode is sponsored by…

Advertisement